首页> American Journal of Obstetrics and Gynecology> To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

导出原文传递

翻译打印收藏纠错

第一作者： Brand, S.

作者： Brand, S. ^[1] ; Degenhardt, T. ^[2] ; Nyirjesy, P. ^[3] ; Sobel, J. ; Handelsman, C. ; Person, K. ; Schotzinger, R. ; Tavakkol, A.

作者单位： Viamet Pharmaceut Inc, Durham, NC USA ^[1] Wayne State Univ, Detroit, MI USA ^[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA ^[3]

发布时间 2017-07-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American Journal of Obstetrics and Gynecology

2016年215卷6期

821-821页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

American Journal of Obstetrics and Gynecology

2016年215卷6期

821-821页

检索历史清除

To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

American Journal of Obstetrics and Gynecology

相似文献

同项目论文

American Journal of Obstetrics and Gynecology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

American Journal of Obstetrics and Gynecology

相似文献

同项目论文

American Journal of Obstetrics and Gynecology

相关期刊

检索历史清除